146 related articles for article (PubMed ID: 30580340)
21. Sildenafil therapy in secondary pulmonary hypertension: Is there benefit in prolonged use?
Chapman TH; Wilde M; Sheth A; Madden BP
Vascul Pharmacol; 2009; 51(2-3):90-5. PubMed ID: 19386283
[TBL] [Abstract][Full Text] [Related]
22. Pulmonary Vascular Distensibility Predicts Pulmonary Hypertension Severity, Exercise Capacity, and Survival in Heart Failure.
Malhotra R; Dhakal BP; Eisman AS; Pappagianopoulos PP; Dress A; Weiner RB; Baggish AL; Semigran MJ; Lewis GD
Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27301469
[TBL] [Abstract][Full Text] [Related]
23. Sildenafil to improve respiratory rehabilitation outcomes in COPD: a controlled trial.
Blanco I; Santos S; Gea J; Güell R; Torres F; Gimeno-Santos E; Rodriguez DA; Vilaró J; Gómez B; Roca J; Barberà JA
Eur Respir J; 2013 Oct; 42(4):982-92. PubMed ID: 23429918
[TBL] [Abstract][Full Text] [Related]
24. Sildenafil improves hemodynamic parameters in COPD--an investigation of six patients.
Alp S; Skrygan M; Schmidt WE; Bastian A
Pulm Pharmacol Ther; 2006; 19(6):386-90. PubMed ID: 16291503
[TBL] [Abstract][Full Text] [Related]
25. Sildenafil citrate therapy for pulmonary arterial hypertension.
Galiè N; Ghofrani HA; Torbicki A; Barst RJ; Rubin LJ; Badesch D; Fleming T; Parpia T; Burgess G; Branzi A; Grimminger F; Kurzyna M; Simonneau G;
N Engl J Med; 2005 Nov; 353(20):2148-57. PubMed ID: 16291984
[TBL] [Abstract][Full Text] [Related]
26. Severe pulmonary hypertension associated with COPD: hemodynamic improvement with specific therapy.
Girard A; Jouneau S; Chabanne C; Khouatra C; Lannes M; Traclet J; Turquier S; Delaval P; Cordier JF; Cottin V
Respiration; 2015; 90(3):220-8. PubMed ID: 26277885
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the therapeutic effects and side effects of tadalafil and sildenafil after surgery in young infants with pulmonary arterial hypertension due to systemic-to-pulmonary shunts.
Sabri MR; Bigdelian H; Hosseinzadeh M; Ahmadi A; Ghaderian M; Shoja M
Cardiol Young; 2017 Nov; 27(9):1686-1693. PubMed ID: 28994364
[TBL] [Abstract][Full Text] [Related]
28. Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
Blanco I; Gimeno E; Munoz PA; Pizarro S; Gistau C; Rodriguez-Roisin R; Roca J; Barberà JA
Am J Respir Crit Care Med; 2010 Feb; 181(3):270-8. PubMed ID: 19875684
[TBL] [Abstract][Full Text] [Related]
29. Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study.
Sastry BK; Narasimhan C; Reddy NK; Raju BS
J Am Coll Cardiol; 2004 Apr; 43(7):1149-53. PubMed ID: 15063421
[TBL] [Abstract][Full Text] [Related]
30. Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial.
Bermejo J; Yotti R; García-Orta R; Sánchez-Fernández PL; Castaño M; Segovia-Cubero J; Escribano-Subías P; San Román JA; Borrás X; Alonso-Gómez A; Botas J; Crespo-Leiro MG; Velasco S; Bayés-Genís A; López A; Muñoz-Aguilera R; de Teresa E; González-Juanatey JR; Evangelista A; Mombiela T; González-Mansilla A; Elízaga J; Martín-Moreiras J; González-Santos JM; Moreno-Escobar E; Fernández-Avilés F;
Eur Heart J; 2018 Apr; 39(15):1255-1264. PubMed ID: 29281101
[TBL] [Abstract][Full Text] [Related]
31. Is chronic sildenafil therapy safe and clinically beneficial in patients with systolic heart failure?
Amin A; Mahmoudi E; Navid H; Chitsazan M
Congest Heart Fail; 2013; 19(2):99-103. PubMed ID: 23241003
[TBL] [Abstract][Full Text] [Related]
32. Acute effects of sildenafil on exercise pulmonary hemodynamics and capacity in patients with COPD.
Holverda S; Rietema H; Bogaard HJ; Westerhof N; Postmus PE; Boonstra A; Vonk-Noordegraaf A
Pulm Pharmacol Ther; 2008; 21(3):558-64. PubMed ID: 18342559
[TBL] [Abstract][Full Text] [Related]
33. Comparative effectiveness of sildenafil for pulmonary hypertension due to left heart disease with HFrEF.
Jiang R; Wang L; Zhu CT; Yuan P; Pudasaini B; Zhao QH; Gong SG; He J; Liu JM; Hu QH
Hypertens Res; 2015 Dec; 38(12):829-39. PubMed ID: 26202179
[TBL] [Abstract][Full Text] [Related]
34. Survival with sildenafil and inhaled iloprost in a cohort with pulmonary hypertension: an observational study.
Gall H; Sommer N; Milger K; Richter MJ; Voswinckel R; Bandorski D; Seeger W; Grimminger F; Ghofrani HA
BMC Pulm Med; 2016 Jan; 16():5. PubMed ID: 26753921
[TBL] [Abstract][Full Text] [Related]
35. Sildenafil therapy in bronchopulmonary dysplasia-associated pulmonary hypertension: a retrospective study of efficacy and safety.
Tan K; Krishnamurthy MB; O'Heney JL; Paul E; Sehgal A
Eur J Pediatr; 2015 Aug; 174(8):1109-15. PubMed ID: 25796626
[TBL] [Abstract][Full Text] [Related]
36. Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And Exercise Capacity in Diastolic Heart Failure (RELAX) Trial.
Hussain I; Mohammed SF; Forfia PR; Lewis GD; Borlaug BA; Gallup DS; Redfield MM
Circ Heart Fail; 2016 Apr; 9(4):e002729. PubMed ID: 27072860
[TBL] [Abstract][Full Text] [Related]
37. Impact of sildenafil on survival of patients with idiopathic pulmonary arterial hypertension.
Zeng WJ; Sun YJ; Gu Q; Xiong CM; Li JJ; He JG
J Clin Pharmacol; 2012 Sep; 52(9):1357-64. PubMed ID: 21956607
[TBL] [Abstract][Full Text] [Related]
38. Additional use of a phosphodiesterase 5 inhibitor in patients with pulmonary hypertension secondary to chronic systolic heart failure: a meta-analysis.
Wu X; Yang T; Zhou Q; Li S; Huang L
Eur J Heart Fail; 2014 Apr; 16(4):444-53. PubMed ID: 24464734
[TBL] [Abstract][Full Text] [Related]
39. A prospective, randomized study: Evaluation of the effect of rosuvastatin in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
Chogtu B; Kuriachan S; Magazine R; Shetty KR; Kamath A; George MM; Tripathy A; Kumar DM
Indian J Pharmacol; 2016; 48(5):503-508. PubMed ID: 27721534
[TBL] [Abstract][Full Text] [Related]
40. Sildenafil improves six-minute walk distance in chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial.
Rao RS; Singh S; Sharma BB; Agarwal VV; Singh V
Indian J Chest Dis Allied Sci; 2011; 53(2):81-5. PubMed ID: 21545068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
